Bottom line
QAAHBX vs VHT: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and VHT (Vanguard Health Care Index Fund) are both etfs.
VHT is cheaper at 0.09% vs 1.11% — a difference of $102 a year per $10,000 invested.
Over five years, VHT returned +7.2% a year vs +3.9% for QAAHBX (reporting dates differ).
Updated Nov 19, 2026
QAAHBX vs VHT side by side
| QAAHBX | VHT | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | T. Rowe Price | Vanguard |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.09% |
| Annual cost per $10k | $111 | $9 |
| 10-yr cost on $10k (prospectus) | $1,352 | $115 |
| Max front load | None | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +17.8% | +2.7% |
| 5-yr return (annualized) | +3.9% | +7.2% |
| 10-yr return (annualized) | +8.7% | +8.8% |
| Best quarter | +23.4% | +16.5% |
| Worst quarter | −15.8% | −13.1% |
| Net assets (fund) | $751.7M | $19.0B |
| Number of holdings | 277 | 407 |
| Portfolio turnover | 65% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of QAAHBX's top 25 holdings also appear in VHT's top 25.
| Holding | QAAHBX | VHT |
|---|---|---|
| Eli Lilly & Co | 14.06% | 14.04% |
| Johnson & Johnson | 6.64% | 8.47% |
| Unitedhealth Group Inc | 5.88% | 5.45% |
| Abbvie Inc | 5.12% | 6.09% |
| Merck & Co. Inc. | 4.00% | 4.66% |
| Gilead Sciences Inc | 2.79% | 2.64% |
| Thermo Fisher Scientific Inc | 2.53% | 2.93% |
| Vertex Pharmaceuticals Inc | 2.26% | 1.80% |
| Bristol-myers Squibb Co | 2.12% | 1.84% |
| Abbott Laboratories | 1.91% | 2.35% |
| Intuitive Surgical Inc | 1.89% | 2.38% |
| Amgen Inc | 1.80% | 2.87% |
| Stryker Corp | 1.78% | 1.66% |
| Elevance Health Inc | 1.54% | 1.35% |
| Danaher Corp | 1.44% | 1.84% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
FAQ
What is the difference between QAAHBX and VHT?
QAAHBX (T. Rowe Price Health Sciences Portfolio) and VHT (Vanguard Health Care Index Fund) are both etfs. VHT is cheaper at 0.09% vs 1.11% — a difference of $102 a year per $10,000 invested.
Which is cheaper, QAAHBX or VHT?
VHT has the lower expense ratio (0.09%).
Should I own both QAAHBX and VHT?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.